PTN
Palatin Technologies, Inc.
Price Chart
Latest Quote
$11.72
-0.53 (-4.33%)
Current Price
| Previous Close | $12.25 |
| Open | $11.91 |
| Day High | $12.21 |
| Day Low | $11.72 |
| Volume | 12,887 |
Stock Information
| Shares Outstanding | 1.78M |
| Total Debt | $287K |
| Cash Equivalents | $10.16M |
| Revenue | $12.88M |
| Net Income | $-6.25M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $20.85M |
| P/E Ratio | 106.55 |
| EPS (TTM) | $0.11 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.98M |
| Sales | $12.88M |
| Income | $-6.25M |
| Book/sh | $5.96 |
| Cash/sh | $5.71 |
| Employees | 29 |
Financial Ratios
| Quick Ratio | 4.86 |
| Current Ratio | 5.04 |
| Debt/Eq | 2.71 |
Returns & Margins
| ROA | -65.26% |
| ROE | -297.24% |
| Gross Margin | 4.28% |
| Operating Margin | -40.33% |
| Profit Margin | -48.50% |
Ownership
| Insider Ownership | 1.08% |
| Institutional Ownership | 55.58% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -4.82 |
| PEG | 1.62 |
| P/S | 1.62 |
| P/B | 1.97 |
Analyst Data
| Recommendation | none |
| Target Price | $53.50 |
Technical Indicators
| SMA20 | $13.73 |
| SMA50 | $17.07 |
| SMA200 | $15.61 |
| RSI | 31.33 |
| ATR | 0.9464 |
| Shares Float | 1.38M |
| Short Float | 10.33% |
| Short Ratio | 11.43 |
| Volatility | -0.11 |
| Rel Volume | 1.24 |
Performance History
| Week | -14.33% |
| Month | -17.87% |
| Quarter | -43.00% |
| 6 Months | -54.41% |
| YTD | -26.98% |
| Year | +113.09% |
| 3 Years | -89.67% |
| 5 Years | -98.46% |
| 10 Years | -98.09% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $11.72 | 12,900 |
| 2026-06-17 | $12.25 | 3,100 |
| 2026-06-16 | $11.87 | 16,000 |
| 2026-06-15 | $12.50 | 21,700 |
| 2026-06-12 | $13.61 | 6,900 |
| 2026-06-11 | $13.68 | 4,000 |
| 2026-06-10 | $13.64 | 6,800 |
| 2026-06-09 | $14.20 | 4,500 |
| 2026-06-08 | $14.12 | 1,600 |
| 2026-06-05 | $14.15 | 8,000 |
| 2026-06-04 | $14.34 | 12,300 |
| 2026-06-03 | $13.50 | 10,900 |
| 2026-06-02 | $13.90 | 19,300 |
| 2026-06-01 | $14.61 | 21,500 |
| 2026-05-29 | $14.02 | 7,700 |
| 2026-05-28 | $14.00 | 15,800 |
| 2026-05-27 | $14.68 | 7,100 |
| 2026-05-26 | $14.45 | 12,400 |
| 2026-05-22 | $14.88 | 9,500 |
| 2026-05-21 | $14.43 | 6,500 |
| 2026-05-20 | $14.59 | 8,800 |
| 2026-05-19 | $14.27 | 11,400 |
About Palatin Technologies, Inc.
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
đ° Latest News
Palatin Technologies Inc (PTN) Q3 2026 Earnings Call Highlights: Strategic Advances Amidst ...
GuruFocus.com âĸ 2026-05-13T23:03:42ZTranscript: Palatin Techs Q3 2026 Earnings Conference Call
Benzinga âĸ 2026-05-13T15:31:25Z
Palatin Technologies, Inc. Q2 2026 Earnings Call Summary
Moby âĸ 2026-02-18T13:30:00Z
Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising ...
GuruFocus.com âĸ 2026-02-17T23:00:29Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $0 | $97,637 | $418,470 | $217,529 |
| Cost Of Revenue | $0 | $97,637 | $418,470 | $217,529 |
| Total Revenue | $0 | $4,490,090 | $4,853,678 | $1,468,457 |
| Operating Revenue | $0 | $8,875,153 | $12,463,140 | $6,066,530 |
| Expenses | ||||
| Interest Expense | $15,025 | $17,114 | $20,013 | $29,682 |
| Total Expenses | $22,707,839 | $34,768,055 | $38,339,883 | $38,056,905 |
| Other Income Expense | $5,415,515 | $558,966 | $4,794,478 | $419,831 |
| Net Non Operating Interest Income Expense | $-15,025 | $-17,114 | $-20,013 | $-29,682 |
| Interest Expense Non Operating | $15,025 | $17,114 | $20,013 | $29,682 |
| Operating Expense | $22,707,839 | $34,670,418 | $37,921,413 | $37,839,376 |
| Other Non Operating Income Expenses | - | $-696,912 | $-1,115,765 | - |
| Other Operating Expenses | - | - | $-1,027,322 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Interest Income | $-15,025 | $-17,114 | $-20,013 | $-29,682 |
| Normalized Income | $-22,722,864 | $-30,991,991 | $-28,984,647 | $-36,618,130 |
| Net Income From Continuing And Discontinued Operation | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Total Operating Income As Reported | $-17,459,939 | $-22,496,121 | $-32,458,883 | $-36,588,448 |
| Net Income Common Stockholders | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Income | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Income Including Noncontrolling Interests | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Income Continuous Operations | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Pretax Income | $-17,307,349 | $-29,736,113 | $-28,711,740 | $-36,198,299 |
| Special Income Charges | $5,247,900 | $7,781,844 | $1,027,322 | $0 |
| Operating Income | $-22,707,839 | $-30,277,965 | $-33,486,205 | $-36,588,448 |
| Gross Profit | $0 | $4,392,453 | $4,435,208 | $1,250,928 |
| Per Share | ||||
| Diluted EPS | $-32.15 | $-101.16 | $-110.50 | $-189.50 |
| Basic EPS | $-32.15 | $-101.16 | $-110.50 | $-189.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $962,337 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-22,448,922 | $-30,635,802 | $-34,313,639 | $-36,461,780 |
| Total Unusual Items | $5,415,515 | $1,255,878 | $5,910,243 | $419,831 |
| Total Unusual Items Excluding Goodwill | $5,415,515 | $1,255,878 | $5,910,243 | $419,831 |
| Reconciled Depreciation | $258,917 | $339,075 | $288,331 | $126,668 |
| EBITDA (Bullshit earnings) | $-17,033,407 | $-29,379,924 | $-28,403,396 | $-36,041,949 |
| EBIT | $-17,292,324 | $-29,718,999 | $-28,691,727 | $-36,168,617 |
| Diluted Average Shares | $538,348 | $293,951 | $217,803 | $190,875 |
| Basic Average Shares | $538,348 | $293,951 | $217,803 | $190,875 |
| Diluted NI Availto Com Stockholders | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Gain On Sale Of Ppe | $3,130,000 | $7,781,844 | $0 | - |
| Other Special Charges | $-2,117,900 | - | $-1,027,322 | - |
| Gain On Sale Of Security | $167,615 | $-6,525,966 | $4,882,921 | $419,831 |
| Research And Development | $14,898,494 | $22,400,372 | $22,630,577 | $21,327,434 |
| Selling General And Administration | $7,809,345 | $12,270,046 | $15,290,836 | $16,511,942 |
| Tax Provision | - | $0 | $-4,674,999 | $0 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Total Assets | $3,266,954 | $10,742,266 | $17,939,440 | $36,070,794 |
| Total Non Current Assets | $347,526 | $972,598 | $1,617,927 | $1,474,695 |
| Other Non Current Assets | $56,916 | $56,916 | $56,916 | $56,916 |
| Current Assets | $2,919,428 | $9,769,668 | $16,321,513 | $34,596,099 |
| Other Current Assets | $325,695 | $242,272 | $1,080,531 | $1,116,704 |
| Receivables | $29,468 | $0 | $2,915,760 | $1,780,020 |
| Other Receivables | $29,468 | - | - | - |
| Cash Cash Equivalents And Short Term Investments | $2,564,265 | $9,527,396 | $10,982,472 | $29,939,154 |
| Cash And Cash Equivalents | $2,564,265 | $9,527,396 | $7,989,582 | $29,939,154 |
| Cash Equivalents | $2,286,603 | $9,089,113 | $5,789,218 | $29,740,565 |
| Cash Financial | $277,662 | $438,283 | $2,200,364 | $198,589 |
| Prepaid Assets | - | $0 | $816,750 | $815,750 |
| Inventory | - | $0 | $526,000 | $944,471 |
| Accounts Receivable | - | $0 | $2,915,760 | $1,780,020 |
| Debt | ||||
| Total Debt | $163,781 | $590,338 | $1,050,781 | $1,153,850 |
| Long Term Debt And Capital Lease Obligation | $33,969 | $163,782 | $590,337 | $681,805 |
| Current Debt And Capital Lease Obligation | $129,812 | $426,556 | $460,444 | $472,045 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,043,999 | $10,853,763 | $19,919,311 | $19,802,919 |
| Total Non Current Liabilities Net Minority Interest | $33,969 | $1,196,082 | $4,787,481 | $3,543,055 |
| Current Liabilities | $8,010,030 | $9,657,681 | $15,131,830 | $16,259,864 |
| Payables And Accrued Expenses | $7,880,218 | $6,515,281 | $9,250,739 | $8,486,937 |
| Payables | $6,998,806 | $4,101,929 | $4,303,527 | $3,157,617 |
| Accounts Payable | $6,998,806 | $4,101,929 | $4,303,527 | $3,157,617 |
| Other Non Current Liabilities | - | $1,032,300 | $2,083,200 | $2,861,250 |
| Derivative Product Liabilities | - | $0 | $2,113,944 | - |
| Other Current Liabilities | - | $944,150 | $3,856,800 | $5,754,986 |
| Equity | ||||
| Common Stock Equity | $-4,777,119 | $-111,537 | $-1,979,911 | $16,267,835 |
| Preferred Stock Equity | $74 | $40 | $40 | $40 |
| Total Equity Gross Minority Interest | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Stockholders Equity | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Retained Earnings | $-459,073,899 | $-441,766,550 | $-412,030,437 | $-387,993,696 |
| Preferred Securities Outside Stock Equity | - | - | $0 | $0 |
| Other | ||||
| Ordinary Shares Number | $929,597 | $358,532 | $233,134 | $185,418 |
| Share Issued | $929,597 | $358,532 | $233,134 | $185,418 |
| Tangible Book Value | $-4,777,119 | $-111,537 | $-1,979,911 | $16,267,835 |
| Invested Capital | $-4,777,119 | $-111,537 | $-1,979,911 | $16,267,835 |
| Working Capital | $-5,090,602 | $111,987 | $1,189,683 | $18,336,235 |
| Capital Lease Obligations | $163,781 | $590,338 | $1,050,781 | $1,153,850 |
| Total Capitalization | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Additional Paid In Capital | $454,287,484 | $441,651,428 | $409,933,959 | $404,168,822 |
| Capital Stock | $9,370 | $3,625 | $116,607 | $92,749 |
| Common Stock | $9,296 | $3,585 | $116,567 | $92,709 |
| Preferred Stock | $74 | $40 | $40 | $40 |
| Long Term Capital Lease Obligation | $33,969 | $163,782 | $590,337 | $681,805 |
| Current Capital Lease Obligation | $129,812 | $426,556 | $460,444 | $472,045 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $1,771,694 | $1,563,847 | $1,545,896 |
| Current Accrued Expenses | $881,412 | $2,413,352 | $4,947,212 | $5,329,320 |
| Net PPE | $290,610 | $915,682 | $1,561,011 | $1,417,779 |
| Accumulated Depreciation | $-3,516,957 | $-3,258,040 | $-2,918,964 | $-2,630,634 |
| Gross PPE | $3,807,567 | $4,173,722 | $4,479,975 | $4,048,413 |
| Leases | $1,196,706 | $1,196,706 | $1,196,706 | $902,038 |
| Other Properties | $1,220,395 | $1,220,395 | $1,177,868 | $1,038,610 |
| Machinery Furniture Equipment | $1,229,300 | $1,229,300 | $1,229,300 | $1,229,300 |
| Buildings And Improvements | $161,166 | $527,321 | $876,101 | $878,465 |
| Properties | $0 | $0 | $0 | $0 |
| Preferred Shares Number | - | $4,030 | $4,030 | $4,030 |
| Finished Goods | - | $0 | $0 | $418,471 |
| Raw Materials | - | $0 | $526,000 | $526,000 |
| Other Short Term Investments | - | $0 | $2,992,890 | $0 |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-21,306,637 | $-31,503,967 | $-29,705,273 | $-30,184,123 |
| Operating Activities | ||||
| Operating Cash Flow | $-21,306,637 | $-31,461,441 | $-29,271,346 | $-29,922,749 |
| Cash Flow From Continuing Operating Activities | $-21,306,637 | $-31,461,441 | $-29,271,346 | $-29,922,749 |
| Operating Gains Losses | $-3,129,950 | $-879,035 | $-4,190,940 | $-155,425 |
| Investing Activities | ||||
| Investing Cash Flow | $3,130,000 | $12,450,364 | $-3,426,817 | $-261,374 |
| Cash Flow From Continuing Investing Activities | $3,130,000 | $12,450,364 | $-3,426,817 | $-261,374 |
| Capital Expenditure | - | $-42,526 | $-433,927 | $-261,374 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,960,765 | $14,666,042 | $10,995,497 | $0 |
| Financing Cash Flow | $11,213,506 | $20,548,891 | $10,748,591 | $18,358 |
| Cash Flow From Continuing Financing Activities | $11,213,506 | $20,548,891 | $10,748,591 | $18,358 |
| Net Other Financing Charges | $-99,482 | $-56,401 | $-146,062 | $-221,311 |
| Net Common Stock Issuance | $7,960,765 | $14,666,042 | $10,995,497 | $0 |
| Common Stock Issuance | $7,960,765 | $14,666,042 | $10,995,497 | $0 |
| Other | ||||
| Repayment Of Debt | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Interest Paid Supplemental Data | $15,025 | $17,114 | $20,013 | $29,682 |
| End Cash Position | $2,564,265 | $9,527,396 | $7,989,582 | $29,939,154 |
| Beginning Cash Position | $9,527,396 | $7,989,582 | $29,939,154 | $60,104,919 |
| Changes In Cash | $-6,963,131 | $1,537,814 | $-21,949,572 | $-30,165,765 |
| Proceeds From Stock Option Exercised | $3,398,237 | $6,045,642 | $78 | $296,132 |
| Net Issuance Payments Of Debt | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Net Long Term Debt Issuance | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Long Term Debt Payments | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Net Investment Purchase And Sale | $0 | $2,992,890 | $-2,992,890 | $0 |
| Sale Of Investment | $0 | $2,992,890 | $0 | - |
| Net Intangibles Purchase And Sale | $3,130,000 | $9,500,000 | $0 | - |
| Sale Of Intangibles | $3,130,000 | $9,500,000 | $0 | - |
| Net PPE Purchase And Sale | $0 | $-42,526 | $-433,927 | $-261,374 |
| Purchase Of PPE | $0 | $-42,526 | $-433,927 | $-261,374 |
| Change In Working Capital | $-758,791 | $-3,406,846 | $-2,350,350 | $3,439,421 |
| Change In Other Current Liabilities | $-239,143 | $-3,817,848 | $-2,413,638 | $-1,356,251 |
| Change In Payables And Accrued Expense | $-406,757 | $-2,569,249 | $745,384 | $3,650,495 |
| Change In Accrued Expense | $-3,303,634 | $-2,367,651 | $-364,157 | $1,077,838 |
| Change In Payable | $2,896,877 | $-201,598 | $1,109,541 | $2,572,657 |
| Change In Account Payable | $2,896,877 | $-201,598 | $1,109,541 | $2,572,657 |
| Change In Prepaid Assets | $-83,423 | $1,218,846 | $35,173 | $1,127,225 |
| Change In Inventory | $0 | $-1,154,355 | $418,471 | $217,529 |
| Change In Receivables | $-29,468 | $2,915,760 | $-1,135,740 | $-199,577 |
| Changes In Account Receivables | $0 | $2,915,760 | $-1,135,740 | $-199,577 |
| Other Non Cash Items | $-1,751,745 | $348,780 | $-655,983 | $359,348 |
| Stock Based Compensation | $1,382,281 | $1,872,698 | $1,674,337 | $2,505,538 |
| Depreciation Amortization Depletion | $258,917 | $339,075 | $288,331 | $126,668 |
| Depreciation And Amortization | $258,917 | $339,075 | $288,331 | $126,668 |
| Net Foreign Currency Exchange Gain Loss | $50 | $-59,753 | $429,971 | $-389,868 |
| Gain Loss On Sale Of PPE | $-3,130,000 | $-7,781,844 | $0 | - |
| Net Income From Continuing Operations | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Gain Loss On Investment Securities | - | $6,962,562 | $-4,620,911 | $234,443 |
| Purchase Of Investment | - | - | $-2,992,890 | $0 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-06-15